# OSGIN2

## Overview
OSGIN2, or oxidative stress induced growth inhibitor family member 2, is a gene that encodes a protein involved in the cellular response to oxidative stress. The protein encoded by OSGIN2 is part of a family of proteins that play a critical role in regulating cell growth and survival under conditions of oxidative stress. It is implicated in various cellular processes, including DNA repair, cell cycle control, and chaperone-mediated autophagy, which are essential for maintaining cellular homeostasis and influencing cancer cell behavior (Wang2023Clinical; Satta2019A). OSGIN2's expression and activity are modulated by interactions with other proteins and microRNAs, such as miR-199a-5p, which can affect tumor progression and patient outcomes in cancers like gastric cancer and lung adenocarcinoma (Keßler2016miR199a5p; Peng2023A). The gene's involvement in oxidative stress responses and its association with poor prognosis in certain cancers underscore its potential as a target for therapeutic intervention (Wang2023Clinical; Shen2022High).

## Clinical Significance
OSGIN2 is implicated in various cancers, notably gastric cancer (GC), where its high expression is associated with poor prognosis. Studies have shown that OSGIN2 is significantly overexpressed in gastric cancer tissues compared to normal tissues, and its elevated levels correlate with increased tumor proliferation and migration. Knockdown experiments indicate that reducing OSGIN2 expression can inhibit tumor cell proliferation and cause cell cycle arrest, suggesting its role in tumor progression (Wang2023Clinical).

In addition to gastric cancer, OSGIN2 is involved in lung adenocarcinoma (LUAD) as a prognostic factor. High expression levels of OSGIN2 are linked to worse prognosis in LUAD patients, indicating its potential as a malignant factor in this context (Peng2023A).

OSGIN2 is also associated with oxidative stress responses, which can influence cancer cell survival and proliferation. Its interactions with other proteins and genes, such as RIPK2, are noted in various cancers, including ovarian cancer, where alterations in OSGIN2 expression may co-occur with RIPK2 alterations, potentially impacting drug resistance (Shen2022High; Zhang2022A). These findings highlight the clinical significance of OSGIN2 in cancer development and progression.

## Interactions
OSGIN2, a gene involved in oxidative stress response, participates in various protein-protein interactions that are crucial for its role in cellular processes. The protein-protein interaction network of OSGIN2 includes interactions with several proteins such as MSL1, SELENBP1, GSTK1, COA3, MS4A7, DECR1, CA7, CALB1, CALB2, and ENSP00000251218. These interactions suggest that OSGIN2 is involved in processes like DNA repair, oxidative stress regulation, and cell cycle control, which are essential for cancer cell survival and proliferation (Wang2023Clinical).

OSGIN2 is also implicated in the regulation of the chaperone-mediated autophagy pathway, particularly through interactions with the HSP70/BAG3 pathway. This interaction is significant in endothelial cell behavior, affecting cell detachment and adhesion (Satta2019A). Additionally, OSGIN2 is regulated by miR-199a-5p, a microRNA that binds to its 3' untranslated region, acting as a translational repressor. This interaction plays a role in cellular adaptation to hypoxia, influencing tumor progression and patient outcomes in soft tissue sarcoma (Keßler2016miR199a5p). These interactions highlight the multifaceted role of OSGIN2 in cellular stress responses and cancer progression.


## References


1. (Satta2019A) A pivotal role for Nrf2 in endothelial detachment- implications for endothelial erosion of stenotic plaques. This article has 2 citations.

[2. (Wang2023Clinical) Peipei Wang, Ying Zhu, Xinru Jia, Xiangchang Ying, Leitao Sun, and Shanming Ruan. Clinical prognostic value of osgin2 in gastric cancer and its proliferative effect in vitro. Scientific Reports, April 2023. URL: http://dx.doi.org/10.1038/s41598-023-32934-5, doi:10.1038/s41598-023-32934-5. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-32934-5)

[3. (Shen2022High) Yuqing Shen, Hui Lin, Kelie Chen, Wanzhong Ge, Dajing Xia, Yihua Wu, and Weiguo Lu. High expression of ripk2 is associated with taxol resistance in serous ovarian cancer. Journal of Ovarian Research, April 2022. URL: http://dx.doi.org/10.1186/s13048-022-00986-2, doi:10.1186/s13048-022-00986-2. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13048-022-00986-2)

[4. (Zhang2022A) Hanqun Zhang, Yan Ma, Qiuning Zhang, Ruifeng Liu, Hongtao Luo, and Xiaohu Wang. A pancancer analysis of the carcinogenic role of receptor-interacting serine/threonine protein kinase-2 (ripk2) in human tumours. BMC Medical Genomics, April 2022. URL: http://dx.doi.org/10.1186/s12920-022-01239-3, doi:10.1186/s12920-022-01239-3. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12920-022-01239-3)

[5. (Peng2023A) Haijun Peng, Xiaoqing Li, Yanchao Luan, Changjing Wang, and Wei Wang. A novel prognostic model related to oxidative stress for treatment prediction in lung adenocarcinoma. Frontiers in Oncology, January 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1078697, doi:10.3389/fonc.2023.1078697. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1078697)

[6. (Keßler2016miR199a5p) Jacqueline Keßler, Swetlana Rot, Matthias Bache, Matthias Kappler, Peter Würl, Dirk Vordermark, Helge Taubert, and Thomas Greither. Mir-199a-5p regulates hif-1α and osgin2 and its expression is correlated to soft-tissue sarcoma patients’ outcome. Oncology Letters, 12(6):5281–5288, October 2016. URL: http://dx.doi.org/10.3892/ol.2016.5320, doi:10.3892/ol.2016.5320. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/ol.2016.5320)